Will Lester

Consultant Haematologist
University Hospitals Birmingham NHS Foundation Trust

Presentation(s):

• OC 04.4 - Disease Relapse in immune Thrombotic Thrombocytopenic Purpura and treatment with Anti-CD20 Monoclonal Antibodies – 10-years’ experience from the UK TTP Registry

  Saturday, July 9, 2022
  1:45 PM – 2:00 PM

• OC 21.2 - Hemostatic results for up to 6 years following treatment with valoctocogene roxaparvovec, an AAV5-hFVIII-SQ gene therapy for severe hemophilia A

  Sunday, July 10, 2022
  3:00 PM – 3:15 PM

• PB0297 - The use of Obinutuzumab and Ofatumumab in the treatment of immune Thrombotic Thrombocytopenic Purpura

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 33.5 - Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets

  Monday, July 11, 2022
  11:45 AM – 12:00 PM